lemme glp 1 daily para que sirve GLP-1 (NOT SPONSORED) by a dietitian Lemme GLP-1 Daily | lemmelive
Description
LAMP Makes Liraglutide Interesting, Not Settled The LAMP liraglutide trial enrolled 636 patients and reported lower recurrence, HR 0.56, 95% CI 0.34-0.91, P 0.02, plus better 90-day outcomes, OR 1.95, 95% CI 1.28-3.00, P 0.002
Dry and pruritic skin is a common clinical manifestation of SS, with vasculitis being the second most common cutaneous manifestation, and histological examination usually confirms the diagnosis of leukocytoclastic vasculitis (LCV) [284]
[cited 2025 Feb 26]
adjusted OR = 0.91
